GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Sign Up For Our Newsletter

News Articles: tuberculosis vaccine

Munyaradzi Musvosvi, a researcher who works for the South African Tuberculosis Vaccine Initiative, in a storage facility at the University of Cape Town that holds in deep freeze the blood samples of people exposed to TB. He's part of a team working to develop a potential mRNA vaccine by looking at the immune cells in the blood samples.

Frozen cells reveal a clue for a vaccine to block the deadly TB bug

Tuberculosis kills 1.6 million a year — the second deadliest infectious disease after COVID-19. Using immune cells and mRNA technology, scientists in South Africa are working on a new vaccine.

|
By:
  • Nurith Aizenman